Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Net sales	$ 1,873	$ 1,809	$ 3,647	$ 3,570
Cost of products sold	563	530	1,100	1,108
Gross profit	1,310	1,279	2,547	2,462
Operating expenses:
Selling, general and administrative expenses	743	661	1,409	1,292
Research and development expenses	206	223	397	427
Royalty expense	25	47	65	87
Amortization expense	109	101	218	204
Goodwill impairment charges	0	0	0	423
Intangible asset impairment charges	110	53	165	53
Contingent consideration expense (benefit)	(96)	(18)	(118)	(41)
Restructuring charges	15	26	35	36
Litigation-related charges (credits)	267	0	260	130
Gain on divestiture	0	(34)	(12)	(40)
Operating expenses	1,379	1,059	2,419	2,571
Operating income (loss)	(69)	220	128	(109)
Other (expense) income:
Interest expense	(53)	(65)	(108)	(130)
Other, net	18	(3)	22	(3)
Income (loss) before income taxes	(104)	152	42	(242)
Income tax expense (benefit)	(108)	22	(95)	(18)
Net income (loss)	$ 4	$ 130	$ 137	$ (224)
Net income (loss) per common share — basic	$ 0.00	$ 0.10	$ 0.10	$ (0.17)
Net income (loss) per common share — assuming dilution	$ 0.00	$ 0.10	$ 0.10	$ (0.17)
Weighted-average shares outstanding
Basic	1,323.2	1,343.5	1,322.4	1,347.7
Assuming dilution	1,345.0	1,358.6	1,347.1	1,347.7